Performance of Nucleic Acid Amplification Tests for the Detection of NG and CT

Completed · Not applicable

Conditions studied: Neisseria Gonorrhoeae Infection, Chlamydia Trachomatis Infection, Sexually Transmitted Infections

In brief

The purpose of this study was to use participant samples to simultaneously evaluate three nucleic acid amplification tests (NAATs) diagnostic platforms.

Key facts

Study ID

NCT02870101

Run by

Duke University

People needed

2767

Starts

2017-04-10

Expected to finish

2018-03-12

Last updated by the study team

2019-05-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Attending a participating clinic for evaluation of sexually transmitted infections (STIs)
• ≥18 years of age at date of screening
• Able and willing to provide informed consent
• Willing to comply with study procedures, including collection of 4 swabs each from the pharynx and rectum for NG and CT testing

You may not qualify if…

• Receipt of any systemic antibacterial drug in the past 14 days
• Receipt of myelosuppressive chemotherapy in the past 30 days

Where it is running

• AIDS Health Foundation - Hollywood — Hollywood, California, United States
• Los Angeles LGBT Clinic — Los Angeles, California, United States
• Denver Health and Hospital Authority — Denver, Colorado, United States
• AIDS Healthcare Foundation - Miami — Miami, Florida, United States
• University of Miami — Miami, Florida, United States
• Louisiana State University — New Orleans, Louisiana, United States
• Wayne State University — Detroit, Michigan, United States
• University of Pittsburgh — Pittsburgh, Pennsylvania, United States
• Central Texas Clinical Research — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.